Sight Sciences Inc. (SGHT) Price to Earnings Ratio

Corporate emblem and logo of Sight Sciences Inc. (SGHT)

Sight Sciences, Inc. (SGHT) operates within the defensive ophthalmology sector, where stable demand is driven by the critical importance of vision preservation. The company develops microsurgical instrumentation to automate fluid outflow for glaucoma, reducing the burden on surgeons. The current P/E ratio stands at -21.30. This chart illustrates the share price dynamics, while production capacities with prime assets are operating at high utilization.

Sight Sciences Inc (SGHT) Price to Earnings Ratio: for the period 07/04/2022 - 11/15/2026

Comprehensive metric breakdowns and analytics for Sight Sciences (SGHT)

- price and consensus price forecast:
Stock Price Sight Sciences Inc.|SGHT - Price Target Chart
- market capitalization details:
Market Value Sight Sciences Inc.|SGHT - Enterprise Value
- book capitalization information:
Net Assets per Share Sight Sciences, Inc.|SGHT - Company Net Assets|Market Capitalization to Net Assets sightsciences.com|SGHT - Company Total Assets
- debt and solvency information:
Debt to Capital Sight Sciences, Inc.|SGHT - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Sight Sciences|SGHT - Company Total Debt|Debt to Net Assets Ratio Sight Sciences, Inc|SGHT - Company Long-Term Debt|Company Current Liabilities Sight Sciences, Inc.|Immediate Liquidity sightsciences.com
- earnings and market multiples details:
SGHT - Net Profit|Net Profit Forecast Sight Sciences, Inc.|SGHT - P/E Multiple|Market Cap to Projected Earnings Sight Sciences, Inc|SGHT - PEG Multiple|Enterprise Value to EBITDA Ratio Sight Sciences Inc.|SGHT - Operating profit EBITDA|Net earnings per share (EPS TTM) Sight Sciences, Inc.|SGHT - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months sightsciences.com|SGHT - Net earnings per share growth this year|Expected earnings per share trend next year Sight Sciences, Inc.
- issuer revenue and sales details:
SGHT - Revenue and Sales Volume|Company Expected Sales Volume Sight Sciences Inc.|SGHT - Price-to-Revenue Ratio|Projected Price to Revenue Sight Sciences Inc|SGHT - Revenue Growth YoY (Last 12 Months)
General company analysis:Sight Sciences Inc. - SGHT
Original product of sightsciences.com

The high margins of Sight Sciences, Inc. (SGHT) ophthalmology devices create potential for a sharp increase in profit once expansion costs are overcome. This ratio reflects the cost of one dollar of net income, allowing for the determination of the investment payback period. The analyst compares this data with business scaling rates to identify any asset overvaluation. The price-to-earnings ratio trend clearly demonstrates the balance between current expenses and future profitability.

Analysis of competing companies

Price to Earnings Ratio BSX|Price to Earnings Ratio EW (Edwards Lifesciences Corporation)|Business Payback Period ResMed Inc.|P/E Multiple PODD (insulet.com)|ZBH (Zimmer Biomet Holdings, Inc.) - Market Cap to Net Income|CooperSurgical - P/E Multiple|Market Cap to Net Income ALGN|GMED: P/E Multiple|Market Cap to Earnings TransMedics Group (TMDX)|ATEC (Alphatec) - P/E Multiple|Price to Earnings Multiple AORT (Artivion)|Price to Earnings Ratio ENOV (Enovis)|IART (Integra LifeSciences Corp) - Company Value to Net Income|Price to Earnings Ratio Establishment Labs Inc ESTA|BBNX - Price to Earnings Ratio|IRADIMED Corp - P/E Multiple|Market Cap to Earnings Embecta Corp.|TNDM: P/E Multiple|Price to Earnings Multiple AXGN|SIBN (SI-BONE Medical) - P/E Multiple|Orthofix International (OFIX) - Business Payback Period|P/E Multiple BVS|Price to Earnings Ratio OrthoPediatrics KIDS|P/E Multiple TMCI (treace.com)|P/E Multiple Blade Air Mobility SRTA|CARL - Price to Earnings Ratio|RXST: Price to Earnings Ratio|CLPT (ClearPoint) - Price to Earnings Ratio|Stereotaxis, Inc. - Company Value to Net Income|STIM (Neuronetics, Inc) - P/E Multiple|Market Cap to Earnings Orchestra BioMed Inc. OBIO|Price to Earnings Ratio Anika Therapeutics, Inc. (ANIK)|InspireMD, Inc. (NSPR) - Market Cap to Net Income Ratio|Jin Medical International Ltd. - Price to Earnings Ratio|P/E Multiple Vivani VANI|Xtant Medical Holdings, Inc. - P/E Multiple|Business Payback Period NeuroOne NMTC|Modular Medical, Inc. (MODD) - Price to Earnings Ratio|Price to Earnings Ratio Myomo, Inc|Price to Earnings Ratio envoymedical.com|Price to Earnings Ratio Vivos Therapeutics (VVOS)|P/E Multiple NVNO|SINT - Market Cap to Earnings|Price to Earnings Ratio Tenon Medical, Inc. TNON|LFWD: Price to Earnings Multiple|AMIX: Price to Earnings Ratio|Business Payback Period invobioscience.com IVF|BBLG: P/E Multiple|Axonics Modulation Technologies (AXNX) - P/E Multiple|BIOL (Biolase Inc.) - P/E Multiple|Market Cap to Earnings dynatronics.com DYNT|P/E Multiple FNA|Price to Earnings Ratio INVO (INVO Bioscience Inc.)